BackNKGen Biotech- Warrants (01/09/2028) Overview

NKGen Biotech- Warrants (01/09/2028) Current Assets

Track NKGen Biotech- Warrants (01/09/2028)'s current assets ($2.4M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$2.38M
48.16% YoYΔ $774000.00 vs prior year quarter

Peer trimmed avg / median

Loading

NKGen Biotech- Warrants (01/09/2028) Current Assets History

Loading

NKGen Biotech- Warrants (01/09/2028) vs. peers: Current Assets Comparison

Loading

NKGen Biotech- Warrants (01/09/2028) Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

NKGen Biotech- Warrants (01/09/2028) (NKGNW) FAQ

The latest current assets for NKGNW is $2.4M as of March 2025. That compares with $1.6M in the prior-year period — up 48.2% year over year. Investors often review this figure alongside NKGen Biotech- Warrants (01/09/2028)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, NKGNW's current assets moved from $1.6M to $2.4M — a 48.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in NKGen Biotech- Warrants (01/09/2028)'s operating scale or balance-sheet position.

A current assets figure of $2.4M for NKGNW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting NKGNW's current assets ($2.4M), review year-over-year change from $1.6M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.